trending Market Intelligence /marketintelligence/en/news-insights/trending/i4vklqoqlnbvjj3xseagkg2 content esgSubNav
In This List

Theratechnologies appoints new director as company grows

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Theratechnologies appoints new director as company grows

Theratechnologies Inc. appointed Gary Littlejohn as a new independent director to its board.

Littlejohn most recently worked as interim CEO of Helix BioPharma Corp.

The company's board decided to appoint additional directors, taking into account the growth of the company, said Dawn Svoronos, chair of the Theratechnologies board.

Theratechnologies is a Canadian specialty pharmaceutical company focused on developing therapies for orphan medical conditions, including HIV.